CD8A and neoplasm: The addition of rapamycin preserved antigen-specific CD8+ tumor-infiltrating lymphocytes (TIL) and enhanced IFNγ secretion in both peripheral and infiltrating CD8+ T cells, leading to upregulation of MHC class I expression (84).